Consensus on the use of neutrophil-stimulating hematopoietic growth factors in clinical practice: an international viewpoint
- 1 May 1997
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 8 (4) , 263-275
- https://doi.org/10.1016/s0924-8579(97)00022-8
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancerPublished by Elsevier ,1996
- Economic Effect of Myeloid Growth Factors on Cancer TreatmentClinical Immunotherapeutics, 1994
- Quality of life of patients with severe chronic neutropenia receiving long-term treatment with granulocyte colony-stimulating factorJAMA, 1993
- Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapyEuropean Journal Of Cancer, 1993
- Do Practice Guidelines Guide Practice?New England Journal of Medicine, 1989
- Effects of Recombinant Human Granulocyte Colony-Stimulating Factor on Neutropenia in Patients with Congenital AgranulocytosisNew England Journal of Medicine, 1989
- Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow TransplantationNew England Journal of Medicine, 1988
- Effects of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor in Patients with Myelodysplastic SyndromesNew England Journal of Medicine, 1987
- High-Dose Therapy and Autologous Bone Marrow Transplantation after Failure of Conventional Chemotherapy in Adults with Intermediate-Grade or High-Grade Non-Hodgkin's LymphomaNew England Journal of Medicine, 1987
- Chronic NeutropeniaMedicine, 1979